Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs).

Clinical trial NCT06736288 · RECRUITING

Trial details

NCT number: NCT06736288
Sponsor: Laboratorio Farmaceutico SIT srl
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Respiratory Infection Lower Respiratory Tract Infection (LRTI)

Start date: 2025-10-21
Primary completion: 2027-04-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.